Mariska Kemna

1.3k total citations
53 papers, 803 citations indexed

About

Mariska Kemna is a scholar working on Surgery, Biomedical Engineering and Transplantation. According to data from OpenAlex, Mariska Kemna has authored 53 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Surgery, 18 papers in Biomedical Engineering and 17 papers in Transplantation. Recurrent topics in Mariska Kemna's work include Transplantation: Methods and Outcomes (33 papers), Mechanical Circulatory Support Devices (18 papers) and Renal Transplantation Outcomes and Treatments (17 papers). Mariska Kemna is often cited by papers focused on Transplantation: Methods and Outcomes (33 papers), Mechanical Circulatory Support Devices (18 papers) and Renal Transplantation Outcomes and Treatments (17 papers). Mariska Kemna collaborates with scholars based in United States, Canada and United Kingdom. Mariska Kemna's co-authors include Yuk M. Law, Erin L. Albers, Hannah A. Valantine, Edward B. Stinson, Gerald M. Reaven, Sharon Hunt, Y.-D. Ida Chen, Borah Hong, Sharon A. Hunt and John S. Schroeder and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Mariska Kemna

47 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariska Kemna United States 15 526 250 222 215 158 53 803
Warren A. Zuckerman United States 17 359 0.7× 139 0.6× 371 1.7× 161 0.7× 218 1.4× 63 901
Costanzo-Nordin Mr United States 17 479 0.9× 195 0.8× 258 1.2× 137 0.6× 94 0.6× 24 638
V. A. Starnes United States 18 636 1.2× 96 0.4× 239 1.1× 159 0.7× 139 0.9× 37 872
María J. Paniagua‐Martín Spain 15 399 0.8× 114 0.5× 237 1.1× 135 0.6× 93 0.6× 65 634
Hardesty Rl United States 15 522 1.0× 169 0.7× 159 0.7× 214 1.0× 80 0.5× 43 660
Erin L. Albers United States 13 203 0.4× 86 0.3× 147 0.7× 78 0.4× 110 0.7× 50 408
M Redonnet France 16 468 0.9× 113 0.5× 365 1.6× 133 0.6× 218 1.4× 55 771
H Laks United States 17 463 0.9× 135 0.5× 315 1.4× 180 0.8× 144 0.9× 46 765
Johanna M. Kwakkel‐van Erp Netherlands 17 306 0.6× 132 0.5× 71 0.3× 58 0.3× 95 0.6× 52 615
Jonas Yserbyt Belgium 16 422 0.8× 111 0.4× 27 0.1× 89 0.4× 128 0.8× 23 555

Countries citing papers authored by Mariska Kemna

Since Specialization
Citations

This map shows the geographic impact of Mariska Kemna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariska Kemna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariska Kemna more than expected).

Fields of papers citing papers by Mariska Kemna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariska Kemna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariska Kemna. The network helps show where Mariska Kemna may publish in the future.

Co-authorship network of co-authors of Mariska Kemna

This figure shows the co-authorship network connecting the top 25 collaborators of Mariska Kemna. A scholar is included among the top collaborators of Mariska Kemna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariska Kemna. Mariska Kemna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kronmal, Richard A., Erin L. Albers, Joshua Friedland‐Little, et al.. (2023). Mycophenolic acid therapeutic drug monitoring using area under the curve in pediatric heart transplant recipients. Clinical Transplantation. 37(11). e15087–e15087.
2.
Morray, Brian H., et al.. (2023). Applying the Hybrid Concept as a Bridge to Transplantation in Infants Without Hypoplastic Left Heart Syndrome. Pediatric Cardiology. 45(2). 323–330. 1 indexed citations
3.
4.
McMullan, D. Michael, Yuk M. Law, Mariska Kemna, et al.. (2022). Waitlist and posttransplant outcomes of critically ill infants awaiting heart transplantation managed without ventricular assist device support. Pediatric Transplantation. 26(6). e14308–e14308. 2 indexed citations
5.
Cantor, Ryan S., Devin Koehl, Deipanjan Nandi, et al.. (2022). The evolution of pediatric heart retransplantation over three decades: An analysis from the PHTS. The Journal of Heart and Lung Transplantation. 41(6). 791–801. 6 indexed citations
6.
Kronmal, Richard A., Thor A. Wagner, Mariska Kemna, et al.. (2022). Association Between Cytomegalovirus Serostatus, Antiviral Therapy, and Allograft Survival in Pediatric Heart Transplantation. Transplant International. 35. 10121–10121. 3 indexed citations
7.
Albers, Erin L., Joshua Friedland‐Little, Borah Hong, et al.. (2021). Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant. Pediatric Transplantation. 26(1). e14126–e14126. 6 indexed citations
8.
Kemna, Mariska, et al.. (2020). A rare pediatric case of left ventricular outflow tract infective endocarditis in hypertrophic cardiomyopathy. JTCVS Techniques. 4. 281–282. 2 indexed citations
9.
Rutledge, Joe C., Mariska Kemna, Erin L. Albers, et al.. (2019). A fatal case of bortezomib‐induced lung toxicity in a young adult heart transplant recipient. Pediatric Transplantation. 24(1). e13628–e13628. 1 indexed citations
10.
Evers, Patrick D., Neal W. Jorgensen, Borah Hong, et al.. (2019). Outcomes of low-intensity biopsy surveillance for rejection in paediatric cardiac transplantation. Cardiology in the Young. 29(7). 910–916. 7 indexed citations
11.
Johnson, Jonathan N., Sunkyung Yu, Ray Lowery, et al.. (2018). TREATMENT VARIATION AND ITS IMPLICATION FOR SEVERE FONTAN-ASSOCIATED PROTEIN LOSING ENTEROPATHY. Journal of the American College of Cardiology. 71(11). A624–A624.
12.
Schumacher, Kurt R., Sunkyung Yu, Ryan J. Butts, et al.. (2018). Fontan-associated protein-losing enteropathy and post‒heart transplant outcomes: A multicenter study. The Journal of Heart and Lung Transplantation. 38(1). 17–25. 37 indexed citations
13.
Warner, Paul, Erin L. Albers, Mariska Kemna, et al.. (2018). Donor‐specific anti‐HLA antibody production following pediatric ABO‐incompatible heart transplantation. Pediatric Transplantation. 23(2). e13332–e13332. 5 indexed citations
14.
Jorgensen, Neal W., Erin L. Albers, Mariska Kemna, et al.. (2017). Feasibility and interpretation of global longitudinal strain imaging in pediatric heart transplant recipients. Pediatric Transplantation. 21(4). 10 indexed citations
15.
Albers, Erin L., et al.. (2015). Eosinophil count, allergies, and rejection in pediatric heart transplant recipients. The Journal of Heart and Lung Transplantation. 34(8). 1103–1111. 12 indexed citations
16.
Sullivan, Patrick M., Paul Warner, Mariska Kemna, et al.. (2014). HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients. The Journal of Heart and Lung Transplantation. 34(7). 950–957. 41 indexed citations
17.
Hong, Borah, Meghan Delaney, Paul Warner, et al.. (2014). Human Leukocyte Antigen Sensitization in Pediatric Patients Exposed to Mechanical Circulatory Support. ASAIO Journal. 60(3). 317–321. 17 indexed citations
18.
Boucek, Robert J., et al.. (2014). Immune cell function assay in pediatric heart transplant recipients. Pediatric Transplantation. 18(5). 485–490. 4 indexed citations
19.
20.
Rickenbacher, Peter, Mariska Kemna, Fausto J. Pinto, et al.. (1996). CORONARY ARTERY INTIMAL THICKENING IN THE TRANSPLANTED HEART. Transplantation. 61(1). 46–53. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Warren A. Zuckerman Breakdown of academic impact, for papers by Costanzo-Nordin Mr Breakdown of academic impact, for papers by V. A. Starnes Breakdown of academic impact, for papers by María J. Paniagua‐Martín Breakdown of academic impact, for papers by Hardesty Rl Breakdown of academic impact, for papers by Erin L. Albers Breakdown of academic impact, for papers by M Redonnet Breakdown of academic impact, for papers by H Laks Breakdown of academic impact, for papers by Johanna M. Kwakkel‐van Erp Breakdown of academic impact, for papers by Jonas Yserbyt
Rankless by CCL
2026